Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELICO: Intravenous lidocaine in head and neck cancer surgery
2015-005799-90Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lidocaine in head and neck cancer (HNC), sponsored by Hospices Civils de Lyon. Primary endpoint: Postoperative morphine consumption over 48 hours. Started Sep 2016; status: completed.
02
Drugs
lidocaine
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on 2015-005799-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005799-90.